Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP1A1 | P05023 | 16/20 | 0.89 |
| ▸ | ATP1B1 | P05026 | 16/20 | 0.89 |
| ▸ | ATP1B2 | P14415 | 16/20 | 0.89 |
| ▸ | ATP1A2 | P50993 | 16/20 | 0.89 |
| ▸ | ATP1B3 | P54709 | 16/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.89 |
| ▸ | TP53 | P04637 | 2/20 | 0.89 |
| ▸ | NPC1 | O15118 | 1/20 | 0.89 |
| ▸ | GLA | P06280 | 1/20 | 0.89 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.89 |
| ▸ | STAT3 | P40763 | 1/20 | 0.89 |
| ▸ | RECQL | P46063 | 1/20 | 0.89 |
| ▸ | RAB9A | P51151 | 1/20 | 0.89 |
| ▸ | RORC | P51449 | 1/20 | 0.89 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.89 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.89 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.89 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.89 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metildigoxin SCHEMBL14769389 | 1.00 | ATP1A1 (0.89) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Metildigoxin SCHEMBL43349 | 1.00 | ATP1A1 (0.89) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Metildigoxin SCHEMBL12841143 | 1.00 | ATP1A1 (0.89) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Metildigoxin SCHEMBL6598684 | 0.97 | ATP1A1 (0.94) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL8200838 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL13354340 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL16144399 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL22904197 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL15959376 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL12841137 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4686757-A1 | INHIBITORS OF EXPRESSION AND/OR FUNCTION | e-therapeutics PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| EP-3897657-A2 | <SUP2/>? <SUB2/>?+? ?NA/K <NS1:SUP>+</NS1:SUP>?ATPASE INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF METASTASIS | Universität Basel (CH) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020127943-A2 | NA+/K+ ATPASE INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF METASTASIS | UNIVERSITÄT BASEL (CH) | 2020-06-25 | — | — | WO | disclosed |
| US-20110250297-A1 | Treatment of Hyperproliferative Disorders Using Cardiac Glycosides | EPICENTRX, INC. | 2011-10-13 | — | — | US | disclosed |
| WO-2010036973-A1 | TREATMENT OF HYPERPROLIFERATIVE DISORDERS USING CARDIAC GLYCOSIDES | COMGENRX, INC. (US) | 2010-04-01 | — | — | WO | disclosed |